Does GLOFITAMAB-GXBM Cause Diffuse large b-cell lymphoma recurrent? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Diffuse large b-cell lymphoma recurrent have been filed in association with GLOFITAMAB-GXBM. This represents 1.8% of all adverse event reports for GLOFITAMAB-GXBM.
9
Reports of Diffuse large b-cell lymphoma recurrent with GLOFITAMAB-GXBM
1.8%
of all GLOFITAMAB-GXBM reports
0
Deaths
1
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma recurrent From GLOFITAMAB-GXBM?
Of the 9 reports, 1 (11.1%) required hospitalization.
Is Diffuse large b-cell lymphoma recurrent Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GLOFITAMAB-GXBM. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does GLOFITAMAB-GXBM Cause?
Cytokine release syndrome (107)
Disease progression (68)
Off label use (68)
Death (67)
Pyrexia (45)
No adverse event (28)
Immune effector cell-associated neurotoxicity syndrome (25)
Infection (20)
Pneumonia (14)
Condition aggravated (12)
What Other Drugs Cause Diffuse large b-cell lymphoma recurrent?
RITUXIMAB (1,359)
CYCLOPHOSPHAMIDE (1,007)
VINCRISTINE (957)
DOXORUBICIN (953)
PREDNISONE (738)
CYTARABINE (406)
DEXAMETHASONE (402)
ETOPOSIDE (375)
CISPLATIN (306)
GEMCITABINE (280)
Which GLOFITAMAB-GXBM Alternatives Have Lower Diffuse large b-cell lymphoma recurrent Risk?
GLOFITAMAB-GXBM vs GLUCAGON
GLOFITAMAB-GXBM vs GLUCAGON\GLUCAGON\WATER
GLOFITAMAB-GXBM vs GLUCARPIDASE
GLOFITAMAB-GXBM vs GLUCOPHAGE
GLOFITAMAB-GXBM vs GLUCOSAMINE